Simposio Internacional de Ciencias Farmaceúticas "SICF"

Simposio Internacional de Ciencias Farmaceúticas

SICF

recombinant streptokinase (ks) and acute myocardial infarction × thrombolytic therapy ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

Thursday 25
November 2021

Pharmacovigilance of thrombolytic therapy with recombinant streptokinase in patients with Acute Myocardial Infarction.
Dra. María Elisa Jorge Rodríguez

estreptoquinasa recombinante (sk) e infarto agudo de miocardio. farmacovigilancia pharmacovigilance recombinant streptokinase (ks) and acute myocardial infarction terapia trombolítica thrombolytic therapy

BioCubaFarma